Señales en vivo de 128940.KS | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 02:30):

Hanmi Pharm. Co., Ltd. operates as a pharmaceutical company worldwide. It develops treatments for diabetes, obesity, cancer, autoimmune, and rare diseases...

Stats
Volumen de hoy	21 794.00
Volumen promedio	42 388.00
Capitalización de mercado	3 939.66B
EPS	KRW0 ( 2024-04-23 )
Próxima fecha de ganancias	( KRW3 611.06 ) 2024-04-30
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW736.19 (0.24%)

Volumen Correlación

Largo: -0.04 (neutral)

Corto: -0.60 (weak negative)

Signal:(50.325) Neutral

Hanmi Pharm. Co., Ltd. Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Hanmi Pharm. Co., Ltd. Correlación - Moneda/Commodity

-0.17
( neutral )

-0.51
( weak negative )

-0.09
( neutral )

-0.33
( neutral )

-0.14
( neutral )

0.01
( neutral )

Hanmi Pharm. Co., Ltd. Finanzas

Annual	2023
Ingresos:	KRW1 490.89B
Beneficio Bruto:	KRW835.86B (56.06 %)
EPS:	KRW11 522

FY	2023
Ingresos:	KRW1 490.89B
Beneficio Bruto:	KRW835.86B (56.06 %)
EPS:	KRW11 522

FY	2022
Ingresos:	KRW1 331.55B
Beneficio Bruto:	KRW718.55B (53.96 %)
EPS:	KRW6 517.20

FY	2021
Ingresos:	KRW1 203.19B
Beneficio Bruto:	KRW632.75B (52.59 %)
EPS:	KRW5 585.96

Financial Reports:

No articles found.

Hanmi Pharm. Co., Ltd.

Hanmi Pharm. Co., Ltd. operates as a pharmaceutical company worldwide. It develops treatments for diabetes, obesity, cancer, autoimmune, and rare diseases. The company was founded in 1973 and is based in Seoul, South Korea.

Actualizaciones en tiempo real para Hanmi Pharm. Co., Ltd. [128940.KS]

Upcoming Earnings Alert